MARKET

SNCA

SNCA

Seneca Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6168
-0.0453
-6.84%
Closed 19:07 04/01 EDT
OPEN
0.6500
PREV CLOSE
0.6621
HIGH
0.6600
LOW
0.6000
VOLUME
49.93K
TURNOVER
--
52 WEEK HIGH
11.60
52 WEEK LOW
0.5000
MARKET CAP
5.82M
P/E (TTM)
-0.1049
1D
5D
1M
3M
1Y
5Y

Analyst Price Target

The average SNCA stock price target is 26.00 with a high estimate of 26.00 and a low estimate of 26.00.

EPS

SNCA News

More
  • Seneca Biopharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
  • PR Newswire · 11h ago
  • Seneca Biopharma names new execs
  • seekingalpha · 17h ago
  • Seneca Biopharma Announces Executive Appointments and Key Promotion
  • PR Newswire · 21h ago
  • Penny Stocks to Buy Using Technical Analysis for April 2020
  • Investopedia · 1d ago

Industry

Biotechnology & Medical Research
-4.52%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About SNCA

Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.
More

Webull offers kinds of Seneca Biopharma Inc stock information, including NASDAQ:SNCA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNCA stock news, and many more online research tools to help you make informed decisions.